Titre : Vaccins antiviraux

Vaccins antiviraux : Questions médicales fréquentes

Termes MeSH sélectionnés :

JC Virus

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une infection virale ?

Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques.
Infections virales Tests diagnostiques
#2

Quels tests sont utilisés pour les vaccins antiviraux ?

Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité.
Vaccins antiviraux Tests sérologiques
#3

Les symptômes indiquent-ils un besoin de vaccin ?

Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin.
Symptômes Vaccins antiviraux
#4

Comment évaluer l'efficacité d'un vaccin ?

L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée.
Efficacité des vaccins Études cliniques
#5

Les tests de dépistage sont-ils nécessaires avant vaccination ?

Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination.
Dépistage Vaccination

Symptômes 5

#1

Quels symptômes nécessitent un vaccin antiviral ?

Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin.
Symptômes Vaccins antiviraux
#2

Les effets secondaires des vaccins sont-ils fréquents ?

Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers.
Effets secondaires Vaccins antiviraux
#3

Comment distinguer une infection d'un effet secondaire ?

Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires.
Infections virales Effets secondaires
#4

Les symptômes varient-ils selon le type de vaccin ?

Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle.
Types de vaccins Réponse immunitaire
#5

Les symptômes d'une infection virale sont-ils similaires ?

Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue.
Infections virales Symptômes

Prévention 5

#1

Comment les vaccins antiviraux préviennent-ils les infections ?

Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques.
Prévention Vaccins antiviraux
#2

À quel âge doit-on commencer la vaccination antivirale ?

L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance.
Vaccination Enfance
#3

Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?

Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin.
Vaccins antiviraux Grossesse
#4

Les vaccins protègent-ils contre toutes les souches virales ?

Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires.
Souches virales Vaccins antiviraux
#5

Quelle est l'importance de la vaccination de masse ?

La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus.
Vaccination de masse Immunité collective

Traitements 5

#1

Les vaccins antiviraux sont-ils des traitements ?

Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes.
Vaccins antiviraux Traitements antiviraux
#2

Quels traitements sont disponibles après infection ?

Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales.
Antiviraux Infections virales
#3

Les vaccins peuvent-ils réduire la gravité des symptômes ?

Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination.
Vaccins antiviraux Symptômes
#4

Les traitements sont-ils nécessaires après vaccination ?

Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination.
Vaccination Traitements antiviraux
#5

Les vaccins antiviraux nécessitent-ils des traitements préventifs ?

Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition.
Vaccins antiviraux Prévention

Complications 5

#1

Quelles complications peuvent survenir après vaccination ?

Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques.
Complications Réactions allergiques
#2

Les complications sont-elles fréquentes ?

Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques.
Complications Vaccins antiviraux
#3

Comment gérer les complications post-vaccinales ?

Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles.
Gestion des complications Vaccins antiviraux
#4

Les complications varient-elles selon le vaccin ?

Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition.
Profils de complications Vaccins antiviraux
#5

Les complications peuvent-elles affecter l'immunité ?

Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare.
Immunité Complications

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les infections virales ?

Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression.
Facteurs de risque Infections virales
#2

Les antécédents médicaux influencent-ils la vaccination ?

Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin.
Antécédents médicaux Vaccination
#3

Les voyages augmentent-ils le risque d'infection ?

Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques.
Voyages Infections virales
#4

Les personnes âgées ont-elles plus de risques ?

Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections.
Personnes âgées Complications
#5

Le mode de vie influence-t-il le risque d'infection ?

Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque.
Mode de vie Infections virales
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaccins antiviraux : Questions médicales les plus fréquentes", "headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaccins antiviraux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaccins", "url": "https://questionsmedicales.fr/mesh/D014612", "about": { "@type": "MedicalCondition", "name": "Vaccins", "code": { "@type": "MedicalCode", "code": "D014612", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccins anti-adénovirus", "alternateName": "Adenovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D062705", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-adénovirus", "code": { "@type": "MedicalCode", "code": "D062705", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.024" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA", "alternateName": "AIDS Vaccines", "url": "https://questionsmedicales.fr/mesh/D016915", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA", "code": { "@type": "MedicalCode", "code": "D016915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.050" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la COVID-19", "alternateName": "COVID-19 Vaccines", "url": "https://questionsmedicales.fr/mesh/D000086663", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la COVID-19", "code": { "@type": "MedicalCode", "code": "D000086663", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin ChAdOx1 nCoV-19", "alternateName": "ChAdOx1 nCoV-19", "url": "https://questionsmedicales.fr/mesh/D000090985", "about": { "@type": "MedicalCondition", "name": "Vaccin ChAdOx1 nCoV-19", "code": { "@type": "MedicalCode", "code": "D000090985", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085.063" } } }, { "@type": "MedicalWebPage", "name": "Ad26COVS1", "alternateName": "Ad26COVS1", "url": "https://questionsmedicales.fr/mesh/D000090984", "about": { "@type": "MedicalCondition", "name": "Ad26COVS1", "code": { "@type": "MedicalCode", "code": "D000090984", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085.125" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le cytomégalovirus", "alternateName": "Cytomegalovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022482", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le cytomégalovirus", "code": { "@type": "MedicalCode", "code": "D022482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.120" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la dengue", "alternateName": "Dengue Vaccines", "url": "https://questionsmedicales.fr/mesh/D053059", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la dengue", "code": { "@type": "MedicalCode", "code": "D053059", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.162" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie à virus Ebola", "alternateName": "Ebola Vaccines", "url": "https://questionsmedicales.fr/mesh/D046129", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie à virus Ebola", "code": { "@type": "MedicalCode", "code": "D046129", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.205" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les herpèsvirus", "alternateName": "Herpesvirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022283", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les herpèsvirus", "code": { "@type": "MedicalCode", "code": "D022283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre la varicelle", "alternateName": "Chickenpox Vaccine", "url": "https://questionsmedicales.fr/mesh/D019433", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la varicelle", "code": { "@type": "MedicalCode", "code": "D019433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre le zona", "alternateName": "Herpes Zoster Vaccine", "url": "https://questionsmedicales.fr/mesh/D053061", "about": { "@type": "MedicalCondition", "name": "Vaccin contre le zona", "code": { "@type": "MedicalCode", "code": "D053061", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccin contre le zona", "alternateName": "Herpes Zoster Vaccine", "url": "https://questionsmedicales.fr/mesh/D053061", "about": { "@type": "MedicalCondition", "name": "Vaccin contre le zona", "code": { "@type": "MedicalCode", "code": "D053061", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130.400" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus herpès simplex", "alternateName": "Herpes Simplex Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022301", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus herpès simplex", "code": { "@type": "MedicalCode", "code": "D022301", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.400" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie de Marek", "alternateName": "Marek Disease Vaccines", "url": "https://questionsmedicales.fr/mesh/D022501", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie de Marek", "code": { "@type": "MedicalCode", "code": "D022501", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins antigrippaux", "alternateName": "Influenza Vaccines", "url": "https://questionsmedicales.fr/mesh/D007252", "about": { "@type": "MedicalCondition", "name": "Vaccins antigrippaux", "code": { "@type": "MedicalCode", "code": "D007252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.302" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre l'encéphalite japonaise", "alternateName": "Japanese Encephalitis Vaccines", "url": "https://questionsmedicales.fr/mesh/D022321", "about": { "@type": "MedicalCondition", "name": "Vaccins contre l'encéphalite japonaise", "code": { "@type": "MedicalCode", "code": "D022321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.320" } } }, { "@type": "MedicalWebPage", "name": "Vaccin contre la rougeole", "alternateName": "Measles Vaccine", "url": "https://questionsmedicales.fr/mesh/D008458", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la rougeole", "code": { "@type": "MedicalCode", "code": "D008458", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.404" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antiourlien", "alternateName": "Mumps Vaccine", "url": "https://questionsmedicales.fr/mesh/D009108", "about": { "@type": "MedicalCondition", "name": "Vaccin antiourlien", "code": { "@type": "MedicalCode", "code": "D009108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.488" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les papillomavirus", "alternateName": "Papillomavirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D053918", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les papillomavirus", "code": { "@type": "MedicalCode", "code": "D053918", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.498" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18", "alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18", "url": "https://questionsmedicales.fr/mesh/D000068857", "about": { "@type": "MedicalCondition", "name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18", "code": { "@type": "MedicalCode", "code": "D000068857", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.498.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus para-influenza", "alternateName": "Parainfluenza Vaccines", "url": "https://questionsmedicales.fr/mesh/D022241", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus para-influenza", "code": { "@type": "MedicalCode", "code": "D022241", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.500" } } }, { "@type": "MedicalWebPage", "name": "Vaccins antipoliomyélitiques", "alternateName": "Poliovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D023321", "about": { "@type": "MedicalCondition", "name": "Vaccins antipoliomyélitiques", "code": { "@type": "MedicalCode", "code": "D023321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin antipoliomyélitique inactivé", "alternateName": "Poliovirus Vaccine, Inactivated", "url": "https://questionsmedicales.fr/mesh/D011054", "about": { "@type": "MedicalCondition", "name": "Vaccin antipoliomyélitique inactivé", "code": { "@type": "MedicalCode", "code": "D011054", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623.500" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antipoliomyélitique oral", "alternateName": "Poliovirus Vaccine, Oral", "url": "https://questionsmedicales.fr/mesh/D011055", "about": { "@type": "MedicalCondition", "name": "Vaccin antipoliomyélitique oral", "code": { "@type": "MedicalCode", "code": "D011055", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie d'Aujeszky", "alternateName": "Pseudorabies Vaccines", "url": "https://questionsmedicales.fr/mesh/D022421", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie d'Aujeszky", "code": { "@type": "MedicalCode", "code": "D022421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.632" } } }, { "@type": "MedicalWebPage", "name": "Vaccins antirabiques", "alternateName": "Rabies Vaccines", "url": "https://questionsmedicales.fr/mesh/D011819", "about": { "@type": "MedicalCondition", "name": "Vaccins antirabiques", "code": { "@type": "MedicalCode", "code": "D011819", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.700" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus respiratoires syncytiaux", "alternateName": "Respiratory Syncytial Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022261", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus respiratoires syncytiaux", "code": { "@type": "MedicalCode", "code": "D022261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.730" } } }, { "@type": "MedicalWebPage", "name": "Vaccins anti-rotavirus", "alternateName": "Rotavirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022243", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-rotavirus", "code": { "@type": "MedicalCode", "code": "D022243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.760" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antirubéoleux", "alternateName": "Rubella Vaccine", "url": "https://questionsmedicales.fr/mesh/D012411", "about": { "@type": "MedicalCondition", "name": "Vaccin antirubéoleux", "code": { "@type": "MedicalCode", "code": "D012411", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.779" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre la rougeole, les oreillons et la rubéole", "alternateName": "Measles-Mumps-Rubella Vaccine", "url": "https://questionsmedicales.fr/mesh/D022542", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la rougeole, les oreillons et la rubéole", "code": { "@type": "MedicalCode", "code": "D022542", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.779.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA simien", "alternateName": "SAIDS Vaccines", "url": "https://questionsmedicales.fr/mesh/D018449", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA simien", "code": { "@type": "MedicalCode", "code": "D018449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.790" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antivariolique", "alternateName": "Smallpox Vaccine", "url": "https://questionsmedicales.fr/mesh/D012900", "about": { "@type": "MedicalCondition", "name": "Vaccin antivariolique", "code": { "@type": "MedicalCode", "code": "D012900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.859" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les hépatites virales", "alternateName": "Viral Hepatitis Vaccines", "url": "https://questionsmedicales.fr/mesh/D014761", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les hépatites virales", "code": { "@type": "MedicalCode", "code": "D014761", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccins anti-hépatite A", "alternateName": "Hepatitis A Vaccines", "url": "https://questionsmedicales.fr/mesh/D022362", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-hépatite A", "code": { "@type": "MedicalCode", "code": "D022362", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955.395" } } }, { "@type": "MedicalWebPage", "name": "Vaccins anti-hépatite B", "alternateName": "Hepatitis B Vaccines", "url": "https://questionsmedicales.fr/mesh/D017325", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-hépatite B", "code": { "@type": "MedicalCode", "code": "D017325", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le virus du Nil occidental", "alternateName": "West Nile Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D053060", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le virus du Nil occidental", "code": { "@type": "MedicalCode", "code": "D053060", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.962" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antiamaril", "alternateName": "Yellow Fever Vaccine", "url": "https://questionsmedicales.fr/mesh/D022341", "about": { "@type": "MedicalCondition", "name": "Vaccin antiamaril", "code": { "@type": "MedicalCode", "code": "D022341", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.970" } } } ], "about": { "@type": "MedicalCondition", "name": "Vaccins antiviraux", "alternateName": "Viral Vaccines", "code": { "@type": "MedicalCode", "code": "D014765", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yukai Huang", "url": "https://questionsmedicales.fr/author/Yukai%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Xiao Guo", "url": "https://questionsmedicales.fr/author/Xiao%20Guo", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Yuancheng Zhou", "url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China." } }, { "@type": "Person", "name": "Dongying Liu", "url": "https://questionsmedicales.fr/author/Dongying%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Jingrui Mao", "url": "https://questionsmedicales.fr/author/Jingrui%20Mao", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36723823", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s13365-023-01113-7" } }, { "@type": "ScholarlyArticle", "name": "JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36494784", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12883-022-03004-6" } }, { "@type": "ScholarlyArticle", "name": "Determining host factors contributing to the reactivation of JC virus in kidney transplant recipients.", "datePublished": "2022-08-08", "url": "https://questionsmedicales.fr/article/35941650", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12985-022-01843-w" } }, { "@type": "ScholarlyArticle", "name": "Deep Sequencing and Molecular Characterisation of BK Virus and JC Virus WHO International Reference Materials for Clinical Diagnostic Use.", "datePublished": "2023-05-30", "url": "https://questionsmedicales.fr/article/37376589", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/v15061289" } }, { "@type": "ScholarlyArticle", "name": "A new evaluation of the rearranged non-coding control region of JC virus in patients with colorectal cancer.", "datePublished": "2024-08-12", "url": "https://questionsmedicales.fr/article/39134946", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-12684-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Vaccins antiviraux", "item": "https://questionsmedicales.fr/mesh/D014765" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaccins antiviraux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaccins antiviraux", "description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=JC+Virus#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaccins antiviraux", "description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=JC+Virus#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaccins antiviraux", "description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=JC+Virus#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaccins antiviraux", "description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=JC+Virus#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaccins antiviraux", "description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=JC+Virus#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaccins antiviraux", "description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=JC+Virus#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection virale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les vaccins antiviraux ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité." } }, { "@type": "Question", "name": "Les symptômes indiquent-ils un besoin de vaccin ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un vaccin ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un vaccin antiviral ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Les effets secondaires des vaccins sont-ils fréquents ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers." } }, { "@type": "Question", "name": "Comment distinguer une infection d'un effet secondaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de vaccin ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle." } }, { "@type": "Question", "name": "Les symptômes d'une infection virale sont-ils similaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue." } }, { "@type": "Question", "name": "Comment les vaccins antiviraux préviennent-ils les infections ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques." } }, { "@type": "Question", "name": "À quel âge doit-on commencer la vaccination antivirale ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance." } }, { "@type": "Question", "name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Les vaccins protègent-ils contre toutes les souches virales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires." } }, { "@type": "Question", "name": "Quelle est l'importance de la vaccination de masse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus." } }, { "@type": "Question", "name": "Les vaccins antiviraux sont-ils des traitements ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles après infection ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination." } }, { "@type": "Question", "name": "Les traitements sont-ils nécessaires après vaccination ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination." } }, { "@type": "Question", "name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après vaccination ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques." } }, { "@type": "Question", "name": "Comment gérer les complications post-vaccinales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles." } }, { "@type": "Question", "name": "Les complications varient-elles selon le vaccin ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter l'immunité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les infections virales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils la vaccination ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques." } }, { "@type": "Question", "name": "Les personnes âgées ont-elles plus de risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 18/02/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

36 au total
└─

Vaccins anti-adénovirus

Adenovirus Vaccines D062705 - D20.215.894.899.024
└─

Vaccins contre le SIDA

AIDS Vaccines D016915 - D20.215.894.899.050
└─

Vaccins contre la COVID-19

COVID-19 Vaccines D000086663 - D20.215.894.899.085
└─

Vaccins contre le cytomégalovirus

Cytomegalovirus Vaccines D022482 - D20.215.894.899.120
└─

Vaccins contre la dengue

Dengue Vaccines D053059 - D20.215.894.899.162
└─

Vaccins contre la maladie à virus Ebola

Ebola Vaccines D046129 - D20.215.894.899.205
└─

Vaccins contre les herpèsvirus

Herpesvirus Vaccines D022283 - D20.215.894.899.290
└─

Vaccins antigrippaux

Influenza Vaccines D007252 - D20.215.894.899.302
└─

Vaccins contre l'encéphalite japonaise

Japanese Encephalitis Vaccines D022321 - D20.215.894.899.320
└─

Vaccin contre la rougeole

Measles Vaccine D008458 - D20.215.894.899.404
└─

Vaccin antiourlien

Mumps Vaccine D009108 - D20.215.894.899.488
└─

Vaccins contre les papillomavirus

Papillomavirus Vaccines D053918 - D20.215.894.899.498
└─

Vaccins contre les virus para-influenza

Parainfluenza Vaccines D022241 - D20.215.894.899.500
└─

Vaccins antipoliomyélitiques

Poliovirus Vaccines D023321 - D20.215.894.899.623
└─

Vaccins contre la maladie d'Aujeszky

Pseudorabies Vaccines D022421 - D20.215.894.899.632
└─

Vaccins antirabiques

Rabies Vaccines D011819 - D20.215.894.899.700
└─

Vaccins contre les virus respiratoires syncytiaux

Respiratory Syncytial Virus Vaccines D022261 - D20.215.894.899.730
└─

Vaccins anti-rotavirus

Rotavirus Vaccines D022243 - D20.215.894.899.760
└─

Vaccin antirubéoleux

Rubella Vaccine D012411 - D20.215.894.899.779
└─

Vaccins contre le SIDA simien

SAIDS Vaccines D018449 - D20.215.894.899.790
└─

Vaccin antivariolique

Smallpox Vaccine D012900 - D20.215.894.899.859
└─

Vaccins contre les hépatites virales

Viral Hepatitis Vaccines D014761 - D20.215.894.899.955
└─

Vaccins contre le virus du Nil occidental

West Nile Virus Vaccines D053060 - D20.215.894.899.962
└─

Vaccin antiamaril

Yellow Fever Vaccine D022341 - D20.215.894.899.970
└─└─

Vaccin ChAdOx1 nCoV-19

ChAdOx1 nCoV-19 D000090985 - D20.215.894.899.085.063
└─└─

Ad26COVS1

Ad26COVS1 D000090984 - D20.215.894.899.085.125
└─└─

Vaccin contre la varicelle

Chickenpox Vaccine D019433 - D20.215.894.899.290.130
└─└─

Vaccins contre les virus herpès simplex

Herpes Simplex Virus Vaccines D022301 - D20.215.894.899.290.400
└─└─

Vaccins contre la maladie de Marek

Marek Disease Vaccines D022501 - D20.215.894.899.290.500
└─└─

Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 D000068857 - D20.215.894.899.498.500
└─└─

Vaccin antipoliomyélitique inactivé

Poliovirus Vaccine, Inactivated D011054 - D20.215.894.899.623.500
└─└─

Vaccin antipoliomyélitique oral

Poliovirus Vaccine, Oral D011055 - D20.215.894.899.623.750
└─└─

Vaccin contre la rougeole, les oreillons et la rubéole

Measles-Mumps-Rubella Vaccine D022542 - D20.215.894.899.779.500
└─└─

Vaccins anti-hépatite A

Hepatitis A Vaccines D022362 - D20.215.894.899.955.395
└─└─

Vaccins anti-hépatite B

Hepatitis B Vaccines D017325 - D20.215.894.899.955.400
└─└─└─

Vaccin contre le zona

Herpes Zoster Vaccine D053061 - D20.215.894.899.290.130.400

Auteurs principaux

Yukai Huang

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Xiao Guo

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Yuancheng Zhou

2 publications dans cette catégorie

Affiliations :
  • Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.

Dongying Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Jingrui Mao

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Yongai Xiong

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmaceutics, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.

Youcai Deng

2 publications dans cette catégorie

Affiliations :
  • Department of Hematology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China.

Xinghong Gao

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
  • Provincial Department of Education, Key Laboratory of Infectious Disease & Bio-Safety, Zunyi Medical University, Zunyi, Guizhou, China.

Chit Laa Poh

2 publications dans cette catégorie

Affiliations :
  • Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, Malaysia.
Publications dans "Vaccins antiviraux" :

Lianpan Dai

2 publications dans cette catégorie

Affiliations :
  • CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. dailp@im.ac.cn.
Publications dans "Vaccins antiviraux" :

Zhou Xing

2 publications dans cette catégorie

Affiliations :
  • McMaster Immunology Research Centre and Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: xingz@mcmaster.ca.
Publications dans "Vaccins antiviraux" :

Scott B Halstead

1 publication dans cette catégorie

Affiliations :
  • , Rockville, MD, USA. halsteads@erols.com.
Publications dans "Vaccins antiviraux" :

Naina McCann

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: Naina.mccann@paediatrics.ox.ac.uk.
Publications dans "Vaccins antiviraux" :

Daniel O'Connor

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Teresa Lambe

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Andrew J Pollard

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Antonio Lembo

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy; GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :

Antonio Molinaro

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Publications dans "Vaccins antiviraux" :

Cristina De Castro

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: cristina.decastro@unina.it.
Publications dans "Vaccins antiviraux" :

Francesco Berti

1 publication dans cette catégorie

Affiliations :
  • GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :

Sources (10000 au total)

JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient.

JC virus (JCV) is common among healthy individuals and remains latent but may be reactivated under immunosuppressive conditions, resulting in progressive multifocal leukoencephalopathy (PML). Here, we... A 67-year-old female without any disease history was admitted after presenting with rapidly progressive dementia. The preoperative diagnosis was progressive multifocal leukoencephalopathy, and cortico... Although it is a rare, this case demonstrates that JC virus infection within the brain occurs in apparently healthy people. This case may increase our understanding of virus infection when facing the ...

Determining host factors contributing to the reactivation of JC virus in kidney transplant recipients.

The John Cunningham virus (JCV) is the established etiological agent of the polyomavirus-associated nephropathy among renal transplant recipients. In the present study, we aimed to determine the proba... Urine and plasma samples were collected from a total of 120 consecutive renal-transplanted patients without preliminary screening from Jan 2018 to Mar 2019. After DNA extraction, the simultaneous dete... The prevalence of JCV viruria and viremia among renal transplant recipients were 26 (21.67%) and 20 (16.67%), respectively. A significant association was observed between the JCV and two risk factors,... It seems that the discovery of potential risk factors, including immunological and non-immunological elements, may offer a possible preventive or therapeutic approach in the JCV disease episodes. The ...

Deep Sequencing and Molecular Characterisation of BK Virus and JC Virus WHO International Reference Materials for Clinical Diagnostic Use.

Reactivation of JC and BK polyomaviruses during immunosuppression can lead to adverse clinical outcomes. In renal transplant recipients, BKV-associated nephropathy can result in graft loss, while in p... Comprehensive sequence characterisation of each preparation using short- and long-read next-generation sequencing technologies was performed with additional corroborative independent digital PCR (dPCR... The analysed genomes displayed subpopulations frequently characterised by complex gene re-arrangements, duplications and deletions.... Despite the recognition of such polymorphisms using high-resolution sequencing methodologies, the ability of these reference materials to act to enhance assay harmonisation did not appear significantl...

A new evaluation of the rearranged non-coding control region of JC virus in patients with colorectal cancer.

Several studies have reported the presence of JC virus (JCV) in human tumors, The association of JCV and CRC remains controversial. This study aimed to evaluate the rearranged NCCR region of the detec... In this case-control study, tumor tissues (n = 60), adjacent normal tissues (n = 60), and urine samples (n = 60) of the CRC patients were collected. The nested PCR was employed to detect the VP1 and N... The analysis reveals that JCV DNA was detected in 35/60 (58.3%) tumor tissues, while 36/60 (60.0%) of adjacent normal tissues (p = 0.85). JCV DNA was detected in 42/60 (70.0%) urine samples when compa... A significant proportion of 35%> of the tumor tissue and urine samples of the CRC patients was found to be positive for JCV DNA (P = 0.25). The parallel analysis of tumor and urine samples for JCV DNA...

Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case Report.

JC virus granule cell neuronopathy is a potentially fatal otherwise highly disabling disease without an approved therapeutic option. This case report presents the positive record to T-cell therapy in ... The patient represented with subacute cerebellar symptoms. Diagnosis of JC virus granule cell neuronopathy was made because of infratentorially accentuated brain volume atrophy shown by brain MRI and ... Six doses of virus-specific T cells were administered. Within 12 months after therapy initiation, the patient showed clear clinical benefit with improvement of symptoms, and JC viral DNA load signific... We present the case report of a positive response to T-cell therapy in JC virus granule cell neuronopathy, leading to an improvement of symptoms....

Hot cross bun sign in JC-Virus Granule cell neuronopathy in HIV infected patient - a case report.

John Cunningham virus related granule cell neuronopathy (JCV-GCN) is a rare manifestation of the reactivation of infection of the cerebellar granule cells by the JCV, mostly in immunocompromised indiv... A 27-year-old HIV positive female with JCV-GCN was re-evaluated for chronic ataxia complicated by subacute progressive horizontal diplopia. Cerebrospinal fluid (CSF) had trace Mycobacterium tuberculos... In conclusion, finding of the HCB sign may be indicative of and aid diagnosis of JCV-GCN in the right clinical context. This could be an important neuroimaging marker in this context, that may radiolo...

Combination of low-dose, long-term immunoglobulin and mirtazapine is effective in progressive multifocal leukoencephalopathy caused by JC virus infection.

Progressive multifocal leukoencephalopathy (PML) is an often fatal disease of the central nervous system caused by opportunistic infection of John Cunningham Polyomavirus (JCV). There's still no antiv... A patient presented with progressive acalculia, right-left confusion and visual neglection was recorded. She received 10-year immunosuppressive therapy for dermatomyositis. White matter lesions locate... We demonstrated that the combination treatment of IVIG and mirtazapine was effective in PML. Low-dose, long-term immunoglobulin might regulate the immune status in our case with controlled inflammator...